Wuhan General Group (China), Inc. (WUHN)

0.0000 0.0000 (0.00%) At close: 03:46PM EDT

Wuhan General Group (China), Inc.

6500 Transcanada hwy
Suite 400
Pointe-Claire, QC H9R 0A5
Canada
514-928-7368
https://wuhn.org

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 700

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Carol Pan	Principal Financial Officer, Principal Accounting Officer and Treasurer	60k	N/A	1984
Mr. Jeffrey Robinson	Founder, Chairman & CEO	N/A	N/A	N/A
Mr. Willem Jonker	Chief Operating Officer	N/A	N/A	N/A
Dr. Hyder Ali Khoja A.Ag., M.Sc., Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Ms. Shivani Subudhi	Head of Marketing	N/A	N/A	N/A
Mr. Huang Zhaoqi	Vice General Manager of Turbine and Director	N/A	N/A	1962
Dr. Anna Leralta Morera	Chief Medical Officer	N/A	N/A	N/A
Mr. Samuel Williams	Head of Food Formulations & Functional Foods	N/A	N/A	N/A
Ms. Clementine Toto	Head of African Aromatherapy	N/A	N/A	N/A
Nicola Royce	Managing Director of M2Biome	N/A	N/A	N/A

Amounts are as of 31 December 2012, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

Corporate governance

Wuhan General Group (China), Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.